Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Nautilus Biotechnology, Inc. (NAUT) had Operating Cash Flow per Share of $-0.47 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-70.78M |
|
-- |
|
-- |
|
$81.48M |
|
$-81.48M |
|
$10.70M |
|
$-70.78M |
|
$-70.78M |
|
$-70.78M |
|
$-70.78M |
|
$-70.78M |
|
$-70.78M |
|
$-81.48M |
|
$-77.93M |
|
125.43M |
|
125.43M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$132.83M |
|
$4.08M |
|
$109.92M |
|
$242.74M |
|
$7.63M |
|
-- |
|
$26.38M |
|
$34.01M |
|
$208.73M |
|
$208.73M |
|
$208.73M |
|
126.11M |
|
| Cash Flow Statement Financials | |
$-59.15M |
|
$66.25M |
|
$1.14M |
|
$20.40M |
|
$28.65M |
|
$8.25M |
|
$12.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.91% |
|
-33.91% |
|
-29.16% |
|
-33.91% |
|
$1.66 |
|
$-0.49 |
|
|
Operating Cash Flow per Share |
$-0.47 |